Emerson Clinical Research Institute - Washington - Connecticut Avenue

Washington D.C., District of Columbia 20009

0 studies enrolling now · 1 studies all time

What they study most

COVID-19

Studies at this site

• A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir — Completed